Alexey Golovkin

Prof. Dr. Alexey Golovkin

Almazov National Medical Research Centre, St. Petersburg, Russia
+1
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OKolga kalinina
olga kalinina
AGAlexey Golovkin
Alexey Golovkin
EZEkaterina Zaikova
Ekaterina Zaikova
AAArthur Aquino
Arthur Aquino
VBVadim Bezrukikh
Vadim Bezrukikh
ESEvgeny Shlyakhto
Evgeny Shlyakhto
Hypercytokinemia, found in SARS-CoV-2 infection, contributes to multiple organ dysfunctions with acute respiratory distress syndrome, shock etc. The aim of this study was to describe cytokine storm signatures in patients with acute COVID-19 and to investigate their influence on severity of the infection. Plasma levels of 47 cytokines were investigated in 73 patients with moderate and severe COVID-19 (41 and 32, respectively) and 11 healthy donors (HD). The most elevated levels comparing patients and the HD were observed for seven pro-inflammatory cytokines (IL-6, IL-8, IL-15, IL-18, IL-27, IFNγ, TNFα), three chemokines (GROα, IP-10, MIG), two anti-inflammatory cytokines (IL-1RA, IL-10), and two growth factors (G-CSF, M-CSF). The patients with severe disease had significantly higher levels of FGF-2/FGF-basic, IL-1β, and IL-7 compared to the HD. The two groups of patients differed from each other only based on the levels of EGF, eotaxin, and IL-12 p40. Pneumonia lung injury, characterized by computer tomography, positively correlated with levels of EGF, IP-10, MCP-3 levels and negatively with IL-12 p40. Pro-inflammatory factors including IL-6, TNFα, and IP-10 negatively correlated with the frequency of the circulating T-helper17-like cells (Th17-like) and follicular Th cells that are crucial to develop SARS-CoV-2-specific plasma cells and memory B cells. Obtained data on the cytokine levels illustrate their influence on progression and severity of COVID-19.

30 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
AGAlexey Golovkin
Alexey Golovkin
OKolga kalinina
olga kalinina
VBVadim Bezrukikh
Vadim Bezrukikh
AAArthur Aquino
Arthur Aquino
EZEkaterina Zaikova
Ekaterina Zaikova
Igor KudryavtsevIgor Kudryavtsev
Igor Kudryavtsev
Background: The immunological changes associated with COVID-19 are largely unknown. Methods: Patients with COVID-19 showing moderate (n = 18; SpO2 > 93%, respiratory rate > 22 per minute, CRP > 10 mg/L) and severe (n = 23; SpO2 < 93%, respiratory rate >30 per minute, PaO2/FiO2 ≤ 300 mmHg, permanent oxygen therapy, qSOFA > 2) infection, and 37 healthy donors (HD) were enrolled. Circulating T- and B-cell subsets were analyzed by flow cytometry. Results: CD4+Th cells were skewed toward Th2-like phenotypes within CD45RA+CD62L− (CM) and CD45RA–CD62L− (EM) cells in patients with severe COVID-19, while CM CCR6+ Th17-like cells were decreased if compared with HD. Within CM Th17-like cells “classical” Th17-like cells were increased and Th17.1-like cells were decreased in severe COVID-19 cases. Circulating CM follicular Th-like (Tfh) cells were decreased in all COVID-19 patients, and Tfh17-like cells represented the most predominant subset in severe COVID-19 cases. Both groups of patients showed increased levels of IgD-CD38++ B cells, while the levels of IgD+CD38− and IgD–CD38− were decreased. The frequency of IgD+CD27+ and IgD–CD27+ B cells was significantly reduced in severe COVID-19 cases. Conclusions: We showed an imbalance within almost all circulating memory Th subsets during acute COVID-19 and showed that altered Tfh polarization led to a dysregulated humoral immune response.

1 February 2015 in Applied Surface Science
Verified
Journal Article
Open access
Sergei TverdokhlebovSergei Tverdokhlebov
Sergei Tverdokhlebov
Evgeniy BobasovEvgeniy Bobasov
Evgeniy Bobasov
ESE.V. Shesterikov
E.V. Shesterikov
LAL.V. Antonova
L.V. Antonova
AGAlexey Golovkin
Alexey Golovkin
YAYuri Anissimov
Yuri Anissimov

1 January 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
YTYana Toropova
Yana Toropova
AGAlexey Golovkin
Alexey Golovkin
Anna MalashichevaAnna Malashicheva
Anna Malashicheva
DKDmitry Korolev
Dmitry Korolev
AGAndrey N Gorshkov
Andrey N Gorshkov
MGMichael Galagudza
Michael Galagudza
Over the last decade, magnetic iron oxide nanoparticles (IONPs) have drawn much attention for their potential biomedical applications. However, serious in vitro and in vivo safety concerns continue to exist. In this study, the effects of uncoated, FemOn-SiO2 composite flake-like, and SiO2-FemOn core-shell IONPs on cell viability, function, and morphology were tested 48 h postincubation in human umbilical vein endothelial cell culture. Cell viability and apoptosis/necrosis rate were determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and annexin V-phycoerythrin kit, respectively. Cell morphology was evaluated using bright-field microscopy and forward and lateral light scattering profiles obtained with flow cytometry analysis. All tested IONP types were used at three different doses, that is, 0.7, 7.0, and 70.0 µg. Dose-dependent changes in cell morphology, viability, and apoptosis rate were shown. At higher doses, all types of IONPs caused formation of binucleated cells suggesting impaired cytokinesis. FemOn-SiO2 composite flake-like and SiO2-FemOn core-shell IONPs were characterized by similar profile of cytotoxicity, whereas bare IONPs were shown to be less toxic. The presence of either silica core or silica nanoflakes in composite IONPs can promote cytotoxic effects.

1 October 2014 in Gene
Verified
Journal Article
Closed access
AGAlexey Golovkin
Alexey Golovkin
APAnastasia Ponasenko
Anastasia Ponasenko
MKMaria Khutornaya
Maria Khutornaya
AKAnton Kutikhin
Anton Kutikhin
Ramil SalakhovRamil Salakhov
Ramil Salakhov
LBLeonid Barbarash
Leonid Barbarash

24 June 2019 in Materials
Verified
Journal Article
Open access
PDF file
VPValentina A. Petrova
Valentina A. Petrova
DCDaniil D. Chernyakov
Daniil D. Chernyakov
DPDaria Poshina
Daria Poshina
IGIosif V. Gofman
Iosif V. Gofman
DRDmitry P. Romanov
Dmitry P. Romanov
Yury A. SkorikYury A. Skorik
Yury A. Skorik
A bilayer nonwoven material for tissue regeneration was prepared from chitosan (CS) and hyaluronic acid (HA) by needleless electrospinning wherein 10–15 wt% (with respect to polysaccharide) polyethylene oxide was added as spinning starter. A fiber morphology study confirmed the material’s uniform defect-free structure. The roughness of the bilayer material was in the range of 1.5–3 μm, which is favorable for cell growth. Electrospinning resulted in the higher orientation of the polymer structure compared with that of corresponding films, and this finding may be related to the orientation of the polymer chains during the spinning process. These structural changes increased the intermolecular interactions. Thus, despite a high swelling degree of 1.4–2.8 g/g, the bilayer matrix maintained its shape due to the large quantity of polyelectrolyte contacts between the chains of oppositely charged polymers. The porosity of the bilayer CS–HA nonwoven material was twice lower, while the Young’s modulus and break stress were twice higher than that of a CS monolayer scaffold. Therefore, during the electrospinning of the second layer, HA may have penetrated into the pores of the CS layer, thereby increasing the polyelectrolyte contacts between the two polymers. The bilayer CS–HA scaffold exhibited good compatibility with mesenchymal stem cells. This characteristic makes the developed material promising for tissue engineering applications.